Biochemical markers of bone turnover during pregnancy in horses: a longitudinal study

2012 ◽  
Vol 15 (4) ◽  
pp. 793-795 ◽  
Author(s):  
C. Greiner ◽  
E. Cavalier ◽  
B. Remy ◽  
A. Gabriel ◽  
F. Farnir ◽  
...  

Abstract The effect of pregnancy on bone metabolism was investigated in healthy mares. Venous blood samples were collected 7 times from 19 multiparous mares starting at 20-weeks pre-parturition, continuing 6 times in 4-week intervals, including the week of parturition and one week after parturition. Serum concentrations of osteocalcin (OC) and carboxy-terminal cross-linking telopeptide of type I collagen (CTX-I) were determined. Measurement cycles and age had a significant (p < 0.01) influence on OC and CTX-I values. Pregnancy influenced bone metabolism with peak bone formation and resorption values around the time of parturition.

2009 ◽  
Vol 2 (4) ◽  
pp. 157-160
Author(s):  
O Ogueh ◽  
M R Johnson ◽  
A Benjamin

The aim of this study was to determine the effect of heparin thromboprophylaxis during pregnancy on maternal biochemical markers of bone metabolism. This was a prospective longitudinal study of carboxy terminal pro-peptide of type I collagen (PICP) and cross-linked carboxyterminal telopeptide of type I collagen (ICTP) levels in 15 women, who had heparin thromboprophylaxis during pregnancy compared with those of 18 normal pregnant controls. During pregnancy, the rate of change of PICP and ICTP in women who had heparin thromboprophylaxis was similar to those of women who did not ( P = 0.184 for PICP, and P = 0.129 for ICTP), and PICP and ICTP levels at individual time points were similar in both groups. Therefore, heparin thromboprophylaxis during pregnancy does not affect maternal biochemical markers of bone metabolism.


2017 ◽  
Author(s):  
Μαρία Παύλου

Η ιδιοπαθής υπερασβεστιουρία (ΙΥΑ) στα παιδιά έχει επιπολασμό 2,2-17,7%. Ποσοστό 2635% των ασθενών εμφανίζει μειωμένη οστική πυκνότητα, που αποδίδεται μάλλον σε αυξημένη οστική απορρόφηση και/ή οστικό ανασχηματισμό, καθώς καταγράφεται φυσιολογική κατά μήκος αύξηση των οστών στα περισσότερα παιδιά με ΙΥΑ. Περιορισμένες είναι οι μελέτες εκτίμησης βιοχημικών δεικτών οστικού μεταβολισμού, αλλά και γονιδιακού ελέγχου σε παιδιά με ΙΥΑ στην διεθνή βιβλιογραφία και καμία στην ελληνική. Επίσης, δεν πραγματοποιήθηκαν μελέτες εκτίμησης των κυτταροκινών οστεοκλαστογένεσης οστεοπροτεγερίνη (osteoprotegerin, OPG) και sRANKL (soluble receptor activator of nuclear factor kB ligand) σε ασθενείς με ΙΥΑ. Σκοπός της μελέτης ήταν η εκτίμηση των βιοχημικών δεικτών οστικής παραγωγής, αλκαλική φωσφατάση (alkaline phosphatase, ALP) και οστεοκαλσίνη (osteocalcin, OC) και οστικής απορρόφησης β-Crosslaps (serum Carboxy-terminal cross-linking telopeptide of type I collagen) και της OPG και sRANKL στον ορό σε παιδιά με ΙΥΑ. Επίσης έγινε γονιδιακή ανάλυση των πολυμορφισμών του γονιδίου του ασβεστιοευαίσθητου υποδοχέα (Calcium sensing Receptor, CaSR). Πενήντα παιδιά με ΙΥΑ αποτέλεσαν την ομάδα ασθενών και 60 υγιή παιδιά την ομάδα ελέγχου. Οι ασθενείς εκτιμήθηκαν κατά τον χρόνο της διάγνωσης και 3 μήνες μετά την εφαρμογή διαιτητικών οδηγιών αντιμετώπισης της ΙΥΑ. Οι ασθενείς της μελέτης μας είχαν σχετικά ήπια προς μέτρια υπερασβεστιουρία (6,49±2,03 mg/Kg/day) κατά την ένταξη στην μελέτη. Μετά την εφαρμογή των διατροφικών οδηγιών, μείωσαν σημαντικά τα επίπεδα του Ca στα ούρα 24ώρου και τον λόγο του Ca προς κρεατινίνη στα δείγματα ούρων, χωρίς όμως να φτάνουν τις φυσιολογικές τιμές. Τα επίπεδα της ALP και OC και το ύψος των ασθενών δεν διέφεραν από της ομάδας ελέγχου, που δείχνει ανεπηρέαστη οστική παραγωγή στους ασθενείς. Τα επίπεδα των β-Crosslaps των ασθενών, στους δύο χρόνους εκτίμησης, ήταν υψηλότερα από των μαρτύρων, ενώ καταγράφηκε τάση μείωσης της μέσης τιμής μετά την τρίμηνη παρέμβαση. Το εύρημα δείχνει αυξημένη οστική απορρόφηση στους ασθενείς με τάση βελτίωσης κατά τον επανέλεγχο. Ο λόγος β-Crosslaps/OC στους ασθενείς κατά την ένταξη στην μελέτη ήταν αυξημένος συγκριτικά με των μαρτύρων, καταγράφοντας υψηλότερο ρυθμό οστικής απορρόφησης συγκριτικά με οστικής παραγωγής. Τα επίπεδα των OPG και sRANKL των ασθενών, στους δύο χρόνους εκτίμησης δε διέφεραν από των μαρτύρων. Ωστόσο, ο λόγος sRANKL/OPG στους ασθενείς κατά την ένταξη στην μελέτη ήταν ελαφρά χαμηλότερος, πιθανά σαν απάντηση αντιρρόπησης του υψηλότερου ρυθμού οστεοκλαστογένεσης. Από την γονιδιακή ανάλυση των πολυμορφισμών A986S, R990G και Q1011E του CaSR, καταγράφηκε συσχέτιση μόνο του A986S με την ΙΥΑ στα παιδιά της μελέτης. Συμπερασματικά οι ασθενείς της μελέτης μας φαίνεται να έχουν φυσιολογική οστική παραγωγή, αλλά αυξημένη οστική απορρόφηση, που βελτιώθηκε μετά την παρέμβαση. Βρέθηκε συσχέτιση μόνο του πολυμορφισμού A986S του CaSR με την ΙΥΑ. Θεωρούμε χρήσιμη την εκτίμηση των βιοχημικών δεικτών οστικής παραγωγής ALP και OC και απορρόφησης β-Crosslaps στον ορό στα παιδιά με ΙΥΑ, ως μια μη επεμβατική μέθοδο ανίχνευσης διαταραχών οστικού μεταβολισμού και παρακολούθησης της αντιμετώπισης της.


Author(s):  
Elżbieta Skowrońska-Jóźwiak ◽  
Piotr Gałecki ◽  
Ewa Głowacka ◽  
Cezary Wojtyła ◽  
Przemysław Biliński ◽  
...  

Background: Depression and osteoporosis are severe public health problems. There are conflicting findings regarding the influence of depression on bone metabolism. The aim of the presented study was to compare bone turnover markers and vitamin D levels between patients treated for depression and healthy controls. Patients and Methods: We determined a concentration of osteocalcin, carboxy-terminal telopeptide of type I collagen (β-CTX), 25-hydroxyvitamin D (25OHD) and 1,25(OH)2D3 in 99 patients, aged 46.9 ± 11 years, treated for depression, as well as in 45 healthy subjects. Depressive status was determined with the Hamilton Depression Scale (HDRS). Results: In patients treated for depression, we demonstrated significantly lower osteocalcin concentrations (p < 0.03) and higher concentration of β-CTX (result on the border of significance; p = 0.08). Those relationship were stronger in women. The level of 25OHD and 1,25(OH)2D3 did not differ significantly between the examined groups. We observed a negative correlation between the 25OHD and HDRS score after treatment in all patients treated for depression and in subgroups of women and subjects with recurrent depression. Conclusions: Our results indicate that depression is related to disturbances in bone metabolism, especially in women and patients with recurrent depression, suggesting its role in context of osteoporosis development.


2020 ◽  
Vol 59 (8) ◽  
pp. 3527-3535
Author(s):  
David J. Clayton ◽  
Lewis J. James ◽  
Craig Sale ◽  
Iain Templeman ◽  
James A. Betts ◽  
...  

Abstract Purpose Intermittent energy restriction commonly refers to ad libitum energy intake punctuated with 24 h periods of severe energy restriction. This can improve markers of metabolic health but the effects on bone metabolism are unknown. This study assessed how 24 h severe energy restriction and subsequent refeeding affected markers of bone turnover. Methods In a randomised order, 16 lean men and women completed 2, 48 h trials over 3 days. On day 1, participants consumed a 24 h diet providing 100% [EB: 9.27 (1.43) MJ] or 25% [ER: 2.33 (0.34) MJ] of estimated energy requirements. On day 2, participants consumed a standardised breakfast (08:00), followed by an ad libitum lunch (12:00) and dinner (19:30). Participants then fasted overnight, returning on day 3. Plasma concentrations of C-terminal telopeptide of type I collagen (CTX), procollagen type 1 N-terminal propeptide (P1NP) and parathyroid hormone (PTH) were assessed as indices of bone metabolism after an overnight fast on days 1–3, and for 4 h after breakfast on day 2. Results There were no differences between trials in fasting concentrations of CTX, P1NP or PTH on days 1–3 (P > 0.512). During both trials, consuming breakfast reduced CTX between 1 and 4 h (P < 0.001) and PTH between 1 and 2 h (P < 0.05), but did not affect P1NP (P = 0.773) Postprandial responses for CTX (P = 0.157), P1NP (P = 0.148) and PTH (P = 0.575) were not different between trials. Ad libitum energy intake on day 2 was greater on ER [12.62 (2.46) MJ] than EB [11.91 (2.49) MJ]. Conclusions Twenty-four hour severe energy restriction does not affect markers of bone metabolism.


2004 ◽  
Vol 65 (1) ◽  
pp. 104-109 ◽  
Author(s):  
Bianca Carstanjen ◽  
Nicholas R. Hoyle ◽  
Annick Gabriel ◽  
Olaf Hars ◽  
Charlotte Sandersen ◽  
...  

1998 ◽  
Vol 44 (12) ◽  
pp. 2453-2461 ◽  
Author(s):  
Takashi Murakami ◽  
Shozo Kusachi ◽  
Masahiro Murakami ◽  
Issei Sano ◽  
Tadahisa Uesugi ◽  
...  

Abstract To test the hypothesis that in patients with acute myocardial infarction (AMI), changes in the concentrations of the serum carboxy-terminal peptide of type I procollagen (PICP) and the carboxy-terminal telopeptide of type I collagen (ICTP) reflect extracellular matrix reformation and degradation, respectively, in the infarct healing processes, we measured these serum concentrations by RIA and compared their values with left ventricular (LV) indices obtained by left ventriculography. We studied 13 consecutive patients with their first AMI who underwent successful reperfusion. Blood samples were taken the day of admission and on days 2, 3, 4, 5, 7, and 14. LV volume indices were determined at 1 month after AMI, when LV remodeling was almost completed. The serum concentrations of both PICP and ICTP changed in a time-dependent manner. The average serum PICP concentration was lower than 1 SD below the mean control values on days 2 and 3 and increased thereafter, returning to the lower end of the control range at day 14. The area under the curve (AUC) for PICP was significantly correlated with the LV end systolic (ES) and end diastolic (ED) volume indices and LV ejection fraction for the first 14 days after AMI. The serum PICP on days 5–14 was inversely correlated or tended to be correlated with the LVES and LVED volume indices. The average serum ICTP concentrations on admission were within the control range, began to increase on day 2, and reached maximal concentrations on day 5, remaining at a plateau concentration until day 14. Although the AUC of ICTP for 14 days, the ICTP concentrations on days 1 and 14, and the minimal and maximal concentrations were significantly correlated with creatine kinase (CK) release and the period from AMI onset to the peak CK time, the concentrations were not significantly correlated with any LV indices except for the concentration on day 4, which was weakly correlated with the LVES volume index. The serum concentrations of PICP showed a significant time-dependent change that correlated with LV indices, indicating that PICP may provide additional information for evaluating the healing process because it affects LV remodeling after AMI. Although the serum concentration of ICTP changed in association with CK release, the ICTP concentration was found to be a poor indicator for LV indices.


2020 ◽  
Vol 34 (5) ◽  
Author(s):  
Jian‐Chun Lin ◽  
Zhong‐Guo Liu ◽  
Rui‐Ren Liu ◽  
Liang‐Wen Xie ◽  
Huang‐Lin Xie ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document